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A B S T R A C T
Background: Three amphipathic cationic antimicrobial peptides (AMPs) were characterized by determining their
eﬀect on Gram-positive bacteria using Bacillus subtilis strain 168 as a model organism. These peptides were TC19
and TC84, derivatives of thrombocidin-1 (TC-1), the major AMPs of human blood platelets, and Bactericidal
Peptide 2 (BP2), a synthetic designer peptide based on human bactericidal permeability increasing protein (BPI).
Methods: To elucidate the possible mode of action of the AMPs we performed a transcriptomic analysis using
microarrays. Physiological analyses were performed using transmission electron microscopy (TEM), ﬂuorescence
microscopy and various B. subtilis mutants that produce essential membrane bound proteins fused to green
ﬂuorescent protein (GFP).
Results: The transcriptome analysis showed that the AMPs induced a cell envelope stress response (cell mem-
brane and cell wall). The cell membrane stress response was conﬁrmed with the physiological observations that
TC19, TC84 and BP2 perturb the membrane of B. subtilis. Using B. subtilis mutants, we established that the cell
wall stress response is due to the delocalization of essential membrane bound proteins involved in cell wall
synthesis. Other essential membrane proteins, involved in cell membrane synthesis and metabolism, were also
delocalized due to alterations caused by the AMPs.
Conclusions: We showed that peptides TC19, TC84 and BP2 perturb the membrane causing essential proteins to
delocalize, thus preventing the possible repair of the cell envelope after the initial interference with the mem-
brane.
General signiﬁcance: These AMPs show potential for eventual clinical application against Gram-positive bacterial
cells and merit further application-oriented investigation.
1. Introduction
Due to an increase in antimicrobial resistance development, eﬀort
has been placed on understanding the means by which bacteria acquire
resistance and to search for new antimicrobials. To address the latter,
antimicrobial peptides (AMPs) have been proposed as a potential novel
class of antibiotics [1, 2]. AMPs are thought to reduce the chances of
resistance development due to their non-speciﬁc rapid membrane tar-
geting eﬀect [2]. However, the non-speciﬁc activity of AMPs can cause
an increase in toxicity to mammalian cells [1, 2]. Additionally, AMPs
have a low bioavailability, are prone to protease degradation, and the
production cost is higher than for classical antimicrobials [1, 2]. Fur-
thermore, reports have been made of pathogenic bacteria that have
shown to develop resistance against natural AMPs [3]. Thus, rational
design of AMPs has been employed with the intention of developing
cost eﬀective highly active short peptides with simple structures.
Naturally occurring peptides or proteins are used as a starting point for
peptide design, for example peptidomimetic POL7080 derived from
protegrin I (PG-I) [4], semi-synthetic NVB302 derived from deox-
yactagardine B [5], P113 derived from histatin 5 [6] and Omiganan
derived from indolicidin [7].
To understand the distinctive attributes of AMPs that lead to their
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eﬃcient antimicrobial activity, eﬀorts are placed in determining the
mode of action of designed peptides. For this study, peptides TC19 and
TC84, derived from thrombocidin-1 (TC-1) [8], and the designer pep-
tide BP2 [9] were selected. Peptide TC19 and TC84 were derived from
the N-terminal end of TC-1 and were modiﬁed to improve their anti-
microbial activity compared to the native peptide [8]. TC19 and TC84
only diﬀer by one amino acid, i.e. a cysteine (C) was replaced by an
alanine (A) near the C-terminal end, resulting in an increase in stability
of TC84 in 100% human plasma compared to TC19 [8]. Both TC19 and
TC84 showed antimicrobial activity against Staphylococcus aureus [8].
Peptide TC19 further showed to be a broad spectrum antimicrobial by
being active against Staphylococcus epidermidis, Pseudomonas aeruginosa,
and an extended-spectrum beta-lactamase (ESBL)-producing Escherichia
coli [8]. TC19 has antifungal activity against Aspergillus niger and Can-
dida albicans, and has anti-bioﬁlm activity against S. aureus [8]. BP2
was fashioned through molecular modelling and rational design based
on the LPS-binding domains of bactericidal permeability increasing
protein (BPI) [9]. BP2 has shown to be active against both Gram-po-
sitive and -negative bacteria [9–11].
All three peptides are predicted to share common features such as
their amphipathic nature and cationic charge but diﬀer in amino acid
sequence. Noticeably, TC84 contained one alpha-helix promoting ala-
nine residue [12, 13] and BP2 two. In this study, we aimed to determine
the mode of action of TC19, TC84 and BP2 using the Gram-positive
bacterium Bacillus subtilis. We expected to observe a related stress re-
sponse between the TC peptides, but diﬀerent from the response seen
upon exposure to BP2. We found TC19, TC84 and BP2 to be active in
the micro-molar range against B. subtilis. Our transcriptomic analysis
showed that both the cell membrane and cell wall were targeted, which
we conﬁrmed during the physiological observations. We found that
TC19, TC84 and BP2 perturbed the membrane of B. subtilis cells in a
concentration dependent manner without directly damaging the cell
wall. This lead to the delocalization of essential proteins involved in cell
wall synthesis, cell membrane synthesis and metabolism contributing to
the envelope stress. Minor diﬀerences in the stress response between
the TC peptides and the BP2 peptide were observed.
2. Materials and methods
2.1. AMP information, strains used and the culturing conditions
TC19 (LRCMCIKWWSGKHPK), TC84 (LRAMCIKWWSGKHPK) and
BP2 (GKWKLFKKAFKKFLKILAC) were dissolved in 0.01% acetic acid
and stored at −20 °C. Stocks were thawed on ice prior to experiments.
Bacillus subtilis strains used in the study can be found in Table S1. B.
subtilis cultures were prepared in complete minimal medium (CMM).
This medium contained Spizizen's Minimal Medium (SMM), as de-
scribed in Anagnostopoulos & Spizizen (1961) [14], with the mod-
iﬁcations described in Halbedel et al. (2014) [15]. Pre-cultures were
prepared by inoculating a single colony from Luria Broth (LB) solid
medium into 5ml LB medium and culturing overnight. The overnight
culture was inoculated into CMM or LB to have an initial optical density
at an absorbance of 600 nm (OD600) of 0.05 and subsequently incubated
until an OD600 of 0.4 to 0.6 (the early exponential growth phase) was
obtained. The pre-cultures were diluted for each experiment to an
OD600 of 0.2, if not speciﬁed otherwise. Culturing was performed at
37 °C under continuous agitation at 200 rpm where appropriate. Cul-
turing media were supplemented when required. Information about the
medium supplements required for each strain can be found in the Table
S1.
2.2. Determination of the minimal inhibitory concentration (MIC) and
minimal bactericidal concentration (MBC)
To obtain the lowest concentration necessary to have an inhibitory
eﬀect on B. subtilis (strain 168), the MIC was determined. The MBC was
determined to establish whether the AMPs are lethal at concentrations
close to the MIC. The MIC was determined by measuring the OD600 for
24 h in a microtiter plate reader (Multiskan FC, Thermo Scientiﬁc). B.
subtilis cells at an OD600 of 0.02 (1× 107 CFU/ml) were treated in CMM
containing the AMP. A two-fold serial dilution from 56 μM to 0.11 μM
of the AMP was prepared in a ﬁnal reaction volume of 150 μl in each
well. The control consisted of CMM without AMP. The experimental
conditions to determine the MBC were similar to the MIC, but after 24 h
the culture in every well was plated out onto LB solid medium. The MIC
was considered to be the lowest AMP concentration where no out-
growth was observed, meaning no change in OD600 for B. subtilis cells.
The MBC was considered to be the lowest AMP concentration which
killed 99.99% of the culture after 24 h. The Student's t-test was applied
to determine statistical signiﬁcance between two groups.
2.3. Assessing the development of resistance to the AMPs
Adaptation or the development of resistance was evaluated by
performing an evolutionary study. B. subtilis was inoculating at an
OD600 of 0.02 (1×107 CFU/ml) in CMM with AMPs ranging from
56 μM to 0.44 μM. Culturing was performed for 24 h and the MICs were
determined by measuring the OD600. The lowest concentration that had
no detectable growth was noted as the MIC. Cultures that had an OD600
of≥50% of the OD600 of the untreated cultures were selected to be re-
inoculated in fresh CMM containing the AMPs. Cultures were in-
oculated into the fresh medium to a ﬁnal OD600 of 0.02. Cultures were
subjected to repeated exposure to the AMPs for 14 passages.
Ciproﬂoxacin was used as a positive control. Ciproﬂoxacin is an anti-
biotic of the ﬂuoroquinolone class known to target DNA gyrase and
topoisomerase IV, thus inhibiting DNA replication [16]. Results were
reported as fold change in MIC over number of passages.
2.4. Time-kill assay to observe the killing eﬀect of the AMPs on B. subtilis at
concentrations close to the MIC values
To observe the killing eﬀect of the AMPs on B. subtilis cells over
time, a time-kill assay was performed using the MIC concentrations
determined previously. The cell number for the time-kill assay was
increased from 1×107 CFU/ml, used during determining the MIC, to
1×108 CFU/ml. A pre-culture was diluted to an OD600 of 0.2
(1×108 CFU/ml) with CMM and divided into 1ml aliquots. To each
1ml aliquot, the AMP was added to reach a ﬁnal concentration at the
MIC and at values close to the MIC. This was 56 μM to 0.11 μM for
TC19, TC84 and BP2. The control was a culture incubated without
AMPs. From each 1ml reaction, 25 μl was removed and added to 25 μl
of 0.1% w/v polyanetholesulfonic acid sodium salt (SPS), a polyanionic
polymer that neutralizes the cationic AMPs [10, 17]. The samples in
SPS were diluted in 0.85% w/v NaCl (saline solution) to obtain a ten-
fold serial dilution range from 10−1 to 10−6. From the undiluted
sample and dilution series, 10 μl was removed and spotted onto LB solid
medium. The overnight incubation was performed at 37 °C. The number
of CFUs were quantiﬁed and the results were expressed as log10 CFU/
ml. Aliquots were removed at time points 5, 30, 60 and 120min. Three
biological repeats were performed. Concentrations used in subsequent
experiments are based on the time-kill assay results.
2.5. Preparation of RNA for microarray analysis
The sample preparation for RNA isolation was performed by cul-
turing B. subtilis overnight in 200ml CMM. The overnight culture was
diluted with pre-warmed CMM to have a ﬁnal OD600 of 0.02 and vo-
lume of 600ml. When the culture reached an OD600 of 0.4, it was di-
luted with pre-warmed CMM to have a ﬁnal OD600 of 0.2. The culture
was split into 150ml fractions and added to 1 l polypropylene
Erlenmeyer ﬂasks. To each ﬂask AMP was added to have a ﬁnal con-
centration of 3.5 μM TC19 and TC84, and 0.22 μM BP2. These peptide
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concentrations caused a one log reduction in CFU/ml during the time
kill assay. The cultures were incubated for 5min and 120min. SPS was
added to have a ﬁnal concentration of 0.05% w/v and the cells har-
vested by centrifuging for 2min at 10,000 rpm and at 20 °C using the
Sorvall RC-6 (Thermo Scientiﬁc). Residual medium was removed by
centrifuging the pellet for 5min at 4000 rpm. The pellet was snap
frozen using liquid nitrogen for subsequent RNA isolation.
RNA was isolated by initially grinding the frozen pellet with a
mortar and pestle. The ground cells were added to occupy about 50 μl of
a pre-chilled Eppendorf tube. To each Eppendorf tube, 300 μl Trizol was
added. After incubating the mixture for 5min at room temperature
(20 °C), 60 μl chloroform was added and incubation at room tempera-
ture was continued for 3min. The mixture was centrifuged for 15min at
12,000 rpm at 4 °C and the upper aqueous layer removed. This aqueous
layer was added to 1 volume 70% ethanol and the mixture transferred
to a RNeasy MinElute spin column (Qiagen). Subsequently, the method
prescribed by the manufacturer of the RNAease Mini Kit (Qiagen) was
followed.
2.6. Synthesis of labelled cDNA, hybridization, and scanning of the DNA
microarrays
The RNA concentrations were measured on the NanoDrop ND-2000
(Thermo Scientiﬁc). The integrity of the RNA samples was assessed on a
2200 TapeStation system (Agilent Technologies) using the RNA
ScreenTape (Agilent Technologies). Per sample, 5 μg of total RNA was
combined with ArrayControl RNA Spikes (Ambion) and 1 μg random
octamers (Biolegio), denatured at 65 °C for 10min and placed on ice-
water for 5min. Subsequently, a ﬁrst strand master mix was added
containing ﬁrst strand buﬀer (Thermo Fisher Scientiﬁc), 0.5 mM dGAC,
0.35mM dUTP, 0.15mM dUTP-Cy3 (GE Healthcare) and 200 U
SuperScript IV (Thermo Fisher Scientiﬁc). This mixture was subse-
quently incubated for 5min at 25 °C, 60min at 50 °C and 10min at
80 °C. Finally, NaOH was added to hydrolyse the remaining RNA by
heating at 70 °C for 15min. The reaction was stopped by adding MOPS
buﬀer and the labelled cDNA was puriﬁed with the E.Z.N.A. MicroElute
RNA Clean-up Kit (Omega Biotek). Dye incorporation and cDNA yield
were measured on the NanoDrop ND-2000 yielding a frequency of in-
corporation of> 10 pmol/μg.
Each hybridization mixture was made up from 1.1 μg Test (Cy3) and
1.1 μg Reference (Cy5) sample. Samples were dried and 1.98 μl water
was added. The hybridization cocktail was made according to the
manufacturer's instructions (NimbleGen Arrays User's Guide — Gene
Expression Arrays Version 5.0, Roche NimbleGen). To each sample
7.2 μl from this mix was added. The samples were incubated for 5min
at 65 °C and 5min at 42 °C prior to loading. Hybridization samples were
loaded onto a 12× 135 K microarray custom designed against B. subtilis
(Roche NimbleGen). Microarrays were hybridized for 20 h at 42 °C with
the NimbleGen Hybridization System (Roche NimbleGen). Afterwards,
the slides were washed according to the NimbleGen Arrays User's Guide
— Gene Expression Arrays Version 6.0 and scanned with an Agilent
DNA microarray scanner G2565CA (Agilent Technologies). Feature
extraction was performed with NimbleScan v2.6 (Roche NimbleGen).
2.7. Microarray data extraction and processing
The microarray data were analysed using the R statistical language
(https://cran.r-project.org/) with packages made available by the
Bioconductor project (https://www.bioconductor.org/). Gene expres-
sion values were calculated using the robust multi-array average (RMA)
algorithm [18]. The normalized data was statistically analysed for
diﬀerential gene expression using a mixed linear model with coeﬃ-
cients for Block (random), and each experimental treatment (ﬁxed) [19,
20]. A contrast analysis was applied to compare each exposure, which
were 5 or 120min of treatment with the peptide, with the control,
which was the untreated sample. The Fs test statistic [21] was used for
hypothesis testing and the resulting p-values were corrected for false
discoveries according to [22]. Genes were considered to be diﬀeren-
tially expressed when the expression ratio exceeded a factor of two and
showed a signiﬁcant diﬀerence in log expression ratio (p≤ 0.05).
Identiﬁed genes were categorized according to SubtiWiki (http://
subtiwiki.uni-goettingen.de/). The hierarchical clustering was per-
formed using the Euclidean distance method and complete agglom-
eration method.
2.8. Conﬁrming membrane damage using transmission electron microscopy
(TEM)
Physiological changes to B. subtilis after treatment were observed
using TEM. The culture was prepared as mentioned previously in the
time-kill assay and harvested after incubating the culture with the
AMPs for 5 or 120min. One volume of Mc Dowell's ﬁxative was added
to the treated culture and the cells were pelleted using centrifugation
for 2min at 10,000 rpm. The supernatant, containing the ﬁxative and
medium, was removed and undiluted Mc Dowell's ﬁxative added to the
pelleted cells for preservation until further processing.
Negative staining of the cells was performed using uranyl acetate. In
brief, the Mc Dowell's ﬁxative was removed from the sample after
centrifugation. The cells were washed once and re-suspended with
double distilled water. Carbon coated grids were place on top of a 10 μl
aliquot of bacterial cell suspension for 2min and washed 5 times on a
drop of distilled water. The grids were, subsequently, placed on top a
small drop of 3.5% uranyl acetate for 1.5min and excess uranyl acetate
was removed by holding the grids to a ﬁlter paper at an angle of 45°.
The grids were ﬁnally dried in the petri dish with ﬁlter paper prior to
imaging.
The B. subtilis cells on the grids were visualized and examined with a
FEI Technai-12 Spirit Biotwin transmission electron microscope (FEI,
Eindhoven, Netherlands) and micrographs were taken with a Veleta
side-mounted TEM camera using Radius acquisition software (Olympus
Soft Imaging Solutions, Münster, Germany). Image measurements were
performed with processing features within the Radius software
package. One biological repeat was performed.
2.9. Membrane perturbation measurement using the ﬂuorescent dye, Sytox
Green
Sytox Green (Molecular Probes, Invitrogen), a nucleic acid staining
dye that can only penetrate a compromised membrane, was used to
determine whether the AMPs caused membrane perturbation. Flow
cytometry was employed to quantify the number of cells positively
stained with Sytox Green after treatment with the AMPs for 5min. B.
subtilis cells were pelleted using centrifugation at 10000 rpm for 2min
and residual CMM removed. The pellet was re-suspended in 0.85% w/v
NaCl and 5 μM of Sytox Green (Molecular Probes, Invitrogen) added.
The mixture was incubated for 15min in the dark at room temperature.
The stained cells were subsequently washed twice with 0.85% w/v
NaCl and re-suspended in 1ml 0.85% w/v NaCl. Stained and unstained
cells were counted based on ﬂuorescence measurements after exposure
to an argon lamp (488 nm) at an excitation and emission wavelength of
500 to 550 nm, respectively, using the Gallios Flow cytometer
(Beckman Coulter). A total of 10,000 cells were counted and the un-
gated results were reported as % Sytox Green stained cells. Three bio-
logical repeats were performed. Microscopy imaging was performed
using the Olympus BX-60. The Olympus BX-60 was mounted with a
CoolSnap fx (Photometrics) CCD camera and an UPLANFl 100×/1.3 oil
objective (Tokyo, Japan). Microscopy images were analysed in ImageJ
(http://rbsweb.nih.gov/ij/).
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2.10. Bacterial cytological proﬁling using mutants producing green
ﬂuorescent protein (GFP) fusion proteins
B. subtilismutants expressing proteins fused to the GFP, were used to
determine whether the AMPs caused delocalization of proteins involved
in various cellular processes, thus rendering these processes inactive.
Culturing was in CMM containing the required supplements for in-
duction (Table S1). Treatment with the AMPs was for 5min while
shaking at 37 °C. GFP-fused proteins were visualized using the Nikon
Eclipse Ti ﬂuorescence microscope at an excitation wavelength of
395 ± 5 nm and emission wavelength of 509 ± 5 nm. Microscopy
slides were prepared by transferring 0.5 μl culture onto a thin 1.5% w/v
agarose pad on a microscopy slide. These experiments were performed
in duplicate. Quantiﬁcation of images were performed by counting 200
cells of three biological repeats and expressing the results as % cells
with delocalized proteins of the total cells counted. The Nikon Eclipse
Ti was equipped with an Intensilight HG 130W lamp, a C11440-22CU
Hamamatsu ORCA camera, a CFI Plan Apochromat DM 100× oil ob-
jective, an OkoLab stage incubator (Napoli, Italy) and with the NIS
elements software version 4.20.01. Microscopy images were analysed in
ImageJ/Fiji (http://rbsweb.nih.gov/ij/).
3. Results
3.1. Diﬀerences in antimicrobial activity between AMPs are marginal
The MIC and MBC were determined to observe possible diﬀerences
in activity and to obtain the lowest peptide concentrations necessary to
evaluate the mode of action of the AMPs against B. subtilis strain 168.
The diﬀerence between the MIC and MBC values of the AMPs against B.
subtilis were not signiﬁcant (Table 1).
3.2. B. subtilis does not adapt or develop resistance to the AMPs
To determine whether B. subtilis adapts to or develops resistance
against TC19, TC84 and BP2, B. subtilis was passaged 14 times through
various concentrations of TC19, TC84 and BP2. Ciproﬂoxacin, a ﬂuor-
oquinolone that inhibits DNA gyrase, was tested as a positive control for
resistance development. Whereas B. subtilis developed resistance to ci-
proﬂoxacin within 10 passages, the strain was unable to grow at a
concentration higher than two-fold of the MIC of the peptides, showing
that adaption or resistance does not occur against TC19, TC84 or BP2
throughout the 14 passages of the experiment (Fig. 1).
3.3. TC19, TC84 and BP2 kill cells rapidly
The time-kill assay for TC19, TC84 and BP2 against B. subtilis cells
showed a rapid decline in numbers of colony forming units (CFU) at
5min at concentrations of 56 μM to 7 μM for TC19 and TC84, and
3.5 μM to 0.44 μM for BP2 (Fig. 2) against a cell number 10-fold higher
than what was used during the MIC/MBC measurements. Concentra-
tions higher than 3.5 μM BP2 also caused rapid killing and are not
shown. Peptides TC19 and TC84, however, caused a further decline in
Table 1
Minimal inhibitory concentration (MIC) and minimal bactericidal concentra-
tion (MBC) of the antimicrobial peptides against B. subtilis strain 168
(1.5×106 cells/well).
Antimicrobial peptide MIC (μM) MBC (μM)
Mean ± SD Mean ± SD
TC19 7.0 ± 3.3 (n=6) 7.0 ± 4.6 (n=3)
TC84 7.0 ± 4.2 (n=6) 3.5 ± 0.2 (n=3)
BP2 3.2 ± 1.5 (n=6) 3.5 ± 0.2 (n=3)
n is the number of biological repeats performed.
Fig. 1. Adaptation or resistance development of B. subtilis after TC19, TC84 and
BP2 treatment using an evolutionary study. Ciproﬂoxacin was used as a positive
control. Induction of adaptation or resistance was performed by repeated ex-
posure of B. subtilis to ¼MIC, ½MIC, 1×MIC, 2×MIC and 4×MIC, of TC19,
TC84 and BP2 for 14 passages. The lowest concentration that had no detectable
growth after these 14 passages was reported as fold change of the MIC. The
highest detectable fold change observed for each of the peptides was two, which
was considered not to be adaption or resistance development. An inoculum of
1× 107 CFU/ml was used and culturing was performed for 24 h. Two biological
repeats are shown.
Fig. 2. Time-kill curves depicting the numbers of B. subtilis surviving cells after
TC19, TC84 and BP2 treatment.
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CFU upon 30min of incubation. TC19 showed a further decline at
14 μM after 60min, followed by a complete killing of the culture. BP2
only showed a decline at 5min with no bacteria surviving at 3.5 μM.
TC19 and TC84 are thus slower acting compared to BP2. This diﬀerence
could be due to the diﬀerence in net positive charge of TC19 and TC84,
which is 4+, compared to that of BP2 which is 7+. Thus, the elec-
trostatic interaction of BP2 to the net negatively charged cell envelope
of B. subtilis might be greater in the case of BP2 than with TC19 and
TC84. Survival of remaining cells in the incubation could occur due to
the reduction of available peptide in the medium, due to protease de-
gradation or due to binding of the peptides to cells, cell debris, com-
ponents of the medium or to the surface of the microtiter wells (Fig. S1).
Concentrations used in the subsequent experiments were based on the
time kill assay results.
Aliquots of the culture were taken at 0, 5, 30, 60 and 120min.
Surviving cells were expressed as colony forming units (CFU) per ml.
Standard error bars represent three biological repeats. CFU/ml values
that were zero were substituted with one, to display the values on the
graph.
3.4. B. subtilis transcriptional response after treatment with AMPs reveals
cell envelope stress
To elucidate the mode of action of TC19, TC84 and BP2, we ﬁrst
performed a transcriptomic analysis of B. subtilis cells treated with sub-
lethal concentrations at 5 and 120min after peptide addition. B. subtilis
diﬀerentially expressed the highest number of genes in response to
TC19 (Table 2). The majority of the genes diﬀerentially expressed after
treatment with TC84 were also expressed in response to TC19 (Fig. 3).
Five minutes of treatment with BP2 yielded the lowest number of dif-
ferentially expressed genes, and most of these genes were also diﬀer-
entially expressed in response to TC19 and/or TC84 (Fig. 3). No genes
were diﬀerentially expressed after 120min treatment with BP2. The
stress response of TC19, TC84 and BP2 was diﬀerent from that of
known antimicrobials that target cell wall synthesis (D-cycloserine,
oxacillin, ristocetin, bacitracin, vancomycin and amoxicillin), the cell
membrane (the non-ionic detergent Triton X-114), the cell membrane
without permeabilising the membrane (the ionophore monensin) and
compounds that target the cell membrane by permeabilising the
membrane (gramicidin A and polymyxin B) [23] (Fig. 4). The data
show that the stress response of the AMPs was most similar to that of
the detergent, Triton X-114. We chose in our analysis to focus on spe-
ciﬁc regulons to obtain an overview of the response of B. subtilis to the
AMPs. Only key genes that indicate a possible mode of action of the
peptides are mentioned. Individual genes might not be diﬀerentially
expressed by all three peptides.
B. subtilis responded to TC19, TC84 or BP2 by upregulating genes
associated with the following two-component systems (TCSs) and their
cognate genes: the liaIH-liaGFSR operon, the bceRS-bceAB TCS-ABC
transporters, the psdRS-psdAB TCS-ABC transporters, the yxdJKLMyxeA
operon, ytrABCDEF and ywoBCD operons, and the yvrHb regulon (Fig.
S2 and Table S2). B. subtilis induced the expression of genes involved in
all of the TCS mentioned in response to a 5min TC19 exposure. Only
the genes associated with the BceRS TCS, the YtrA regulon, the PsdRS
TCS and the YvrHb regulon were diﬀerentially upregulated in response
to 120min of treatment with TC19. In response to 5min of treatment
with TC84, genes associated with the LiaRS TCS, BceRS TCS, YxdJK
TCS, the YtrA regulator and the YvrHb TCS were responsive. These
genes were not upregulated in response to 5min of treatment with BP2,
except for one gene in the ytrABCDEF operon, and two in the YvrHb
TCS. None of the TCSs and their cognate genes were diﬀerentially up-
regulated after 120min of treatment with TC84 or BP2. When com-
paring the stress response with the above-mentioned antimicrobials,
only Triton X-114, bacitracin and vancomycin exposed cells showed an
induction of expression of the genes associated with the LiaRS TCS [23].
Furthermore, genes associated with the BceRS TCS were only induced
by bacitracin and ristocetin, and those associated with the YtrA reg-
ulator by vancomycin and ristocetin [23].
The LiaRS TCS is upregulated in response to cell wall synthesis in-
hibition but also to membrane perturbation [24–29]. The BceRS TCS,
PsdRS TCS and the YtrA regulon are upregulated during cell wall
synthesis inhibition [24, 25, 30–32]. YxdJK TCS are associated with cell
membrane perturbation [26]. The YvrHb regulon plays a key role in
maintaining the cell envelope integrity by positively regulating wprA,
wapA-yxxG, dltABCDE, sunA, sunT-bdbA-yolJ-bdbB, yvrI-yvrHa and sigX-
rsiX, and negatively regulating the lytABC operon [33, 34].
B. subtilis responded to TC19, TC84 or BP2 by upregulating the
expression of genes under control of the extracytoplasmic function
(ECF) sigma factors SigM, V, W and X, which play a key role in cell
envelope stress response [24–26, 31, 35–44] (Fig. S2). Genes associated
with SigB were also diﬀerentially expressed, but most of the genes
upregulated after 5min and 120min are shared by SigM, W or X (Fig.
S3). Downregulated genes associated with SigB were mostly diﬀeren-
tially expressed after treatment with TC19 for 120min, and the ma-
jority of these genes were not regulated by SigM, W or X (Table S3).
These genes were involved in multidrug resistance and resistance
against ethanol, salt, paraquat, low temperature, peroxide, and other
antimicrobial stimuli (Table S3).
For an overview of the genes regulated and diﬀerentially expressed
by SigM, V, W and X in response to TC19, TC84 or BP2 refer to Table
S4. Results on genes relevant for the mode of action are summarized as
follows. Genes involved in cell wall stress were upregulated. These were
ydaH (also amj), bcrC, the penicillin-binding protein genes pbpX and
pbpE, and ywaC, the biomarker gene for screening cell-wall active
compounds [45]. Similarly, Triton X-114 induced the expression of
pbpE, amoxicillin the ywaC, vancomycin the ydaH, and ristocetin the
bcrC and ywaC [23]. The ydaH gene encodes a lipid II ﬂippase involved
in the transport of lipid II across the membrane [46] and bcrC encodes
Table 2
The number of diﬀerentiallya expressed genes after treatment with the AMPs.
TC19 TC84 BP2
5min 120min 5min 120min 5min 120min
Upregulated 187 528 107 36 39 0
Downregulated 7 470 1 4 0 0
a Genes are considered to be diﬀerentially expressed when the expression
ratio exceeds a factor of two and shows a signiﬁcant diﬀerence in log expression
ratio (p≤ 0.05).
Fig. 3. Venn diagrams depicting the numbers of shared diﬀerentially expressed
genes in response to TC19, TC84 and BP2.
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undecaprenyl pyrophosphate phosphatase important for cell wall
synthesis and is involved in resistance against bacitracin and paraquat
[31, 47, 48]. Genes involved in cell envelope biogenesis (divIB, mreC,
mreD, murB and rodA), and lipoteichoic acid synthesis (yfnI) were also
upregulated [49–54]. These responses indicate that the peptides impose
cell wall stress on the B. subtilis cells.
B. subtilis also responded to TC19 and TC84 by upregulating genes
involved in modifying the cell surface such as the dlt operon, psd, and
oat. DltA, DltB, DltC, DltD and DltE are all involved in the D-alanylation
of teichoic acids and lipoteichoic acids [55]. Psd is a phosphatidylserine
decarboxylase and is involved in the synthesis of phosphatidylethano-
lamine (PE), a zwitterionic phospholipid of the cell membrane [56]. Oat
is involved in O-acetylation of peptidoglycan, a modiﬁcation that has
shown to be involved in resistance of Gram-positive bacteria against
lysozyme [57].
Fatty acid metabolism was increased in response to exposure of B.
subtilis cells to TC19 by the upregulation of yrhJ, a cytochrome P450
monooxygenases (CYP) referred to as P450 CYP102A3 for B. subtilis
[58–60] (Table S4). CYP102A3 hydroxylates branched chain fatty
acids, and the degradation of iso and anteiso fatty acids by CYP102A3
has been proposed as a means of altering the ﬂuidity of the cell mem-
brane [60, 61]. B. subtilis also upregulated ﬂoT, ﬂoA, yuaF and pspA in
response to TC19 and TC84. Genes ﬂoT, ﬂoA and yuaF and involved in
membrane ﬂuidity homeostasis and B. subtilis can alter its membrane
ﬂuidity by upregulating these genes. The phage shock homologue and
biomarker for membrane distortion, PspA, is involved in stabilizing the
membrane [40, 62, 63]. These responses all indicate a response of the
bacteria to cell membrane distortion by the peptides. Interestingly, only
treatment with Triton X-114 showed an upregulation of the expression
of yuaF and pspA [23].
Bacterial cells may experience oxidative stress and DNA damage due
to cell envelope distortion after treatment with the peptides. Indeed we
found bcrC, yqjL, spx and yjbC upregulated, which are associated with
oxidative stress or paraquat resistance [47, 64–69]. Similarly, yqjL was
upregulated by Triton X-114, amoxicillin, vancomycin, ristocetin, and
polymycin B, and yjbC by amoxicillin and ristocetin. Transcription of a
DNA repair gene, recU [70], and DNA integrity scanning gene, disA,
[71] was upregulated. The sigma factor Xpf was diﬀerentially upregu-
lated after treatment with TC19 and TC84, but not after treatment with
BP2. B. subtilis has a suicidal response to DNA-damage by lysing and by
producing the phage-like bacteriocin PBSX bacteriophage particles that
kill strains non-lysogenic for this phage by damaging the cell wall [72].
Xpf positively regulates the expression of genes associated with PBSX
particles production [72]. However, genes regulated by the Xre regulon
were also upregulated after treatment with TC19 and TC84. Xre is a
transcriptional repressor of Xpf [72]. The combined eﬀects of upregu-
lation of Xpf and Xre are unclear.
Finally, the genes fosB, ybfO, ydbS, ydbT, yqeZ, yqfB, sunI, yfhL and
yknWXYZ reported to be involved in resistance to antimicrobials were
upregulated (Table S5). FosB is a metallothiol transferase shown to
confer resistance to fosfomycin and to the antimicrobials produced by
B. amyloliquefaciens [35, 36]. YbfO is similar to an erythromycin es-
terase known to be involved in erythromycin resistance [32]. Genes
ydbS and ydbT are involved in the resistance against the antimicrobials
produced by B. amyloliquefaciens [35]. Genes yqeZ and yqfB as part of
the yqeZyqfAB operon [35] and sunI [73] are involved in sublancin
resistance, and yfhL and the yknWXYZ operon in resistance to the B.
subtilis toxic protein SdpC [35]. The gene encoding SdpC, yvaY, was not
diﬀerentially expressed. However, mutants with deletions of genes
(ones that are non-essential) mentioned above did not show reduced
susceptibility to TC19, TC84 and BP2 (Table S6). Interestingly, Triton
X-114 induced the expression of fosB, ybfO, ydbS, yqeZ, yqfB, yfhL,
yknWXYZ, but none of the other antimicrobials [23].
In summary, the transcriptomic analysis suggested that B. subtilis
responded to the TC19, TC84 and BP2 exposure by upregulating genes
associated with cell membrane distortion and cell wall synthesis. The
induction of other gene sets indicates that alteration to the cell envelope
likely caused oxidative stress and possibly DNA damage. B. subtilis thus
Fig. 4. Hierarchical clustering analysis of gene ex-
pression in response to TC19, TC84, BP2 and other
cell envelope-active antibiotics. Antibiotic treat-
ments included were cell wall synthesis inhibitory
antimicrobials (D-cycloserine, oxacillin, ristocetin,
bacitracin, vancomycin and amoxicillin), a detergent
(Triton X-114), a cell membrane active antimicrobial
that does not permeabilise the membrane (the io-
nophore monensin) and those that do permeabilise
the membrane (gramicidin A and polymyxin B) [23].
Gene expression levels are shown by colour ac-
cording to the colour key, red indicating down-
regulation and green indicating upregulation.
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respond to the changes to the cell envelope by gene expression aimed at
changing the cell surface, altering membrane ﬂuidity and upregulating
genes associated with resistance against known antimicrobials.
3.5. TC19, TC84 and BP2 cause membrane damage
Since the transcriptomic analysis suggested that the cell envelope is
targeted by the peptides, we employed TEM to investigate any struc-
tural changes that the treatment of TC19, TC84 and BP2 might create
after 5min and 120min. Lethal concentrations were used, which were
14 μM TC19 and TC84, and 3.5 μM BP2. Cells treated for 5min with
TC19, TC84 and BP2 stained black with uranyl acetate whereas the
untreated cells appeared grey with black uranyl acetate deposited on
the surface of the cell (Fig. 5). TC19, TC84 and BP2 did not lyse the cells
and no visible cell wall damage was observed at 5min. In contrast, after
120min of exposure, disrupted cells were observed (Fig. 5). Cross
sections of the cells treated for 5min showed an irregularly distributed
and abnormal nucleoid (Fig. 5, red arrows). Uranyl acetate staining of
the cells entirely, implying that membrane perturbation had occurred
since the membrane was permeable to the dye. Membrane permeabi-
lisation, in a peptide concentration dependent manner, was conﬁrmed
using the ﬂuorescent dye Sytox Green (Fig. 6). These ﬁndings suggest
that the cell membrane is the primary target for the peptides. The cell
wall stress response might be a result of cell membrane distortion and
the irregular nucleoid could be a consequence of the loss of cell
membrane integrity.
3.6. Delocalization of membrane bound proteins
To further address the molecular events involved in cell envelope
homeostasis we analysed in more detail protein localization in the cell
membrane starting from the notion that essential cellular processes,
such as cell wall and cell membrane synthesis, occur at the plasma
membrane [74]. To study the localization of various proteins involved
and to aid in the elucidation of their function, we used a panel of
mutant strains expressing proteins fused to green ﬂuorescent protein
(GFP), to investigate whether the membrane proteins delocalized after
treatment with TC19, TC84 and BP2. The B. subtilis mutants were cul-
tured in deﬁned minimal medium (CMM), in which the growth of the
bacteria is slow and protein localization might diﬀer from previous
reports where rich medium was used (Fig. S4). Deﬁned minimal
medium was selected as the exact concentration of each component is
known, unlike rich medium.
MinD was initially evaluated, where MinD together with MinC
forms a complex that inhibits the Z-ring formation [75]. MinD-GFP is
known to localize at the septum and at the cell poles [76]. In non-
treated cells (Fig. 7, image a) MinD-GFP indeed was localized at the
septum, whereas once TC19, TC84 and BP2 were added MinD-GFP
Fig. 5. Transmission electron micrographs (TEM) of B. subtilis after peptide treatment. B. subtilis was treated for 5 and 120min with 14 μM TC19, 14 μM TC84 or
3.5 μM BP2. Negative staining with uranyl acetate was performed of cells after treatment with the peptides and cross sections were performed of the uranyl acetate
stained cells. Negative staining showed cells stained black with uranyl acetate indicating perturbed membranes (treated). Cells with an intact membrane appears grey
with black uranyl acetate on the surface of the cell (untreated). Cross sections of the stained cells after treatment for 5 min with TC19, TC84 and BP2 had irregular
nucleoids compared to the untreated cells (red arrows). After 120min of treatment with the peptides the cross sections reveal lysed cells, while all observed untreated
cells remained intact. Scale bar of microscopy images represent 1 μm.
Fig. 6. Sytox Green staining of B. subtilis after peptide treatment. Sytox Green stained cells were visualized at the green emission wavelength with ﬂuorescence
microscopy and quantiﬁed with ﬂow cytometry. At a high concentration of AMP, 14 μM of TC19 and TC84, and 3.5 μM BP2, membrane perturbation can be observed
as Sytox Green staining of the nucleic acid is visible in image a1, b1 and c1. Membrane perturbation was also detected at a lower concentration of AMP, at 3.5 μM
TC19 and 0.22 μM BP2 as shown in images a2, b2 and c2. Peptide TC84 at a low concentration of 3.5 μM (b2) also caused Sytox Green ﬂuorescent dye to enter the
cells, but the ﬂuorescence was less clearly visible suggesting a lower degree of membrane perturbation. Quantiﬁcation of the Sytox Green staining of the cells suggests
an increase in membrane perturbation with an increase of concentration, as shown in the graph. Microscopy images are overlays of phase contrast and ﬂuorescence
images. Treatment was for 5min and results represent three biological repeats. Scale bar of microscopy images represent 2 μm.
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delocalized. At lethal concentrations, 14 μM TC19 (b1) and TC84 (c1),
and 3.5 μM BP2 (d1), MinD-GFP was evenly distributed throughout the
cells. At sub-lethal concentrations, 3.5 μM TC19 and TC84, and 0.22 μM
BP2, the appearance of MinD-GFP was “spotty”. Such a “spotty” ap-
pearance of MinD-GFP when delocalized has also been observed for B.
subtilis treated with compounds that dissipate the membrane potential,
valinomycin or CCCP [76]. However, the even distribution of the MinD-
GFP as observed after exposure to the high TC19, TC84 and BP2 con-
centrations has never been reported. We suspect that at lethal peptide
concentrations, MinD-GFP dissociates from the membrane due to rapid
cell death, but at sub-lethal concentrations the protein remains attached
but delocalized due to distortion of the membrane. Quantiﬁcation of the
microscopy images showed that MinD-GFP delocalization, both
“spotty” and fully delocalized, occurred in a concentration dependent
manner. This was the case for all GFP-fusion proteins observed.
Therefore, only results for lethal concentrations are shown. We in-
vestigated our microarray data to observe whether B. subtilis is re-
sponding directly to the delocalization of MinD or its associated protein
MinC, but we found no diﬀerential expression of MinD or MinC after 5
or 120min of treatment with the peptides.
Delocalization or dissociation of the MinD-GFP occurred rapidly (≤
5min) (Fig. 7). This was also observed for MreB (Fig. 8). MreB is a cell-
shape determinant that forms an important part of the cell wall
synthesis machinery and is pivotal in maintaining cell membrane
homeostasis [77–79]. Both MinD and MreB requires the presence of a
membrane potential for correct localization [76]. The transcriptomic
analysis revealed that MreB was not diﬀerentially expressed after
treatment with TC19, TC84 and BP2 (Table S7). Expression of the genes
encoding the MreB homologous proteins Mbl and MreBH [78], how-
ever, were upregulated by 1.5 logFC and 4.6 logFC after TC19 treatment
for 120min (Table S7). After treatment with TC84 for 120min MreBH
were upregulated by 1.1 logFC. The upregulation of these genes sug-
gests that B. subtilis respond to the delocalization of these membrane
bound proteins.
The delocalization of MreB, together with the cell wall stress re-
sponse, hinted at the possibility that other cell wall synthesis-associated
proteins might also be delocalized. MreB forms a complex with MreC,
MreD, RodA, MurG, MraY and several PBPs [80–82]. MurG was initially
investigated as it has been shown to delocalize after treatment with the
lipopeptide daptomycin, the cationic hexapeptide MP196, the cyclic
decapeptide gramicidin S and the cyclic hexapeptide cWFW [34, 83,
84]. Treatment with TC19, TC84 and BP2 caused a rapid (≤5min)
delocalization of the MurG-GFP. MurG is a N-acetylglucosamine
transferase that catalysis the addition of N-acetylglucosamine to the N-
acetylmuramic acid residue of lipid I, resulting in the formation of lipid
II [51, 85]. The transcriptomic analysis revealed that B. subtilis re-
sponded to the treatment with TC19 after 120min by upregulating
MurG and genes co-transcribed with MurG, MurB, SpoVE, DivIB and
Sbp (Table S7) [23, 86]. MurB was diﬀerentially expressed in response
to TC84 after 120min. In conclusion, it appears that B. subtilis adjust
the expression of genes associated with MurG functionality in response
to MurG delocalization.
Additional proteins involved in cell wall synthesis that delocalized
after treatment with TC19, TC84 and BP2 were MraY-GFP, PBP2b-GFP,
PonA-GFP and FtsW-GFP. Essential MraY is a phospho-N-acetylmur-
amoyl-pentapeptide transferase that catalyses the transfer of the
phospho-MurNAc-pentapeptide moiety to undecaprenyl phosphate lo-
cated at the membrane, forming lipid I [51, 85]. PonA is a class A pe-
nicillin binding protein (PBP) with both transglycosylase and trans-
peptidase activity [87–90]. MraY and PonA are both dependent on the
proper localization of MreB [91, 92]. Penicillin-binding protein 2b
(PBP2b) is a class B transpeptidase involved in the cell wall synthesis
during cell division [90, 93]. PBP2b together with FtsW forms part of
the divisome responsible for septal cell wall synthesis [94, 95] as well
as for the stabilization of the Z-ring [94]. The Z-ring is formed by the
polymerization of a tubulin-like protein, FtsZ, into a circular structure
at mid-cell [96]. Delocalization of PBP2b, FtsW or FtsZ will prevent
proper formation of the Z-ring, which serves as a scaﬀold for other
proteins involved in synthesizing the septum or cell division site [49],
and will thus interfere with cell division.
A general range of proteins involved in cell membrane synthesis
(PgsA and PlsX), ATP synthesis (AtpA), Krebs' cycle and respiration
(SdhA), cell division (FtsZ and DivIVA), transcription (RpoC), transla-
tion (RpsB) and DNA repair (DnaN and RecA) were selected to assess
whether TC19, TC84 and BP2 aﬀect other cellular functions due to
membrane distortion. Delocalization of all proteins involved in cell
membrane synthesis, ATP synthesis, Kreb's cycle and respiration, and
cell division were observed. However, localization of RpoC and RpsB
localized within the cytosol, and of DnaN and RecA, associated with the
nucleoid, was not aﬀected (Fig. 8). Clearly the abnormal localization of
ATP synthase subunit AtpA is an indication of extensive perturbation of
the cell membrane. In normal cells the AtpA complex is uniformly
distributed at the membrane and its delocalization has been used pre-
viously as an indicator for abnormal membrane curvatures [77].
Fig. 7. Delocalization of membrane bound protein MinD after peptide treatment using B. subtilis mutant MinD-GFP. MinD-GFP is localized at the cell poles and septa
as shown in the ﬂuorescence microscopy image of the untreated B. subtilis mutant MinD-GFP (a). MinD-GFP delocalizes when the membrane potential is dissipated.
Delocalization of the MinD-GFP was observed after treatment with 14 μM and 3.5 μM of TC19 (b1 and b2) and TC 84 (c1 and c2), and with 3.5 μM and 0.22 μM BP2
(d1 and d2). Treatment was for 5min. The graph shows the % of cells with delocalized MinD-GFP from a total of about 600 cells analysed per treatment. The standard
error bars represent three biological repeats. A total of 200 cells were counted of each biological repeat. Scale bar represent 2 μm.
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4. Discussion
TC19, TC84 and BP2 are predicted to share the common features of
being cationic and amphipathic peptides and comply with the char-
acteristics of their class by distorting the cell envelope of B. subtilis in a
non-speciﬁc manner. TC19, TC84 and BP2 were rapidly bactericidal (≤
5min). Furthermore, as expected for this class of antimicrobial pep-
tides, neither of these three peptides caused B. subtilis to develop re-
sistance, as tested by 14 cycles of exposure to the peptides. TC19, TC84
and BP2 caused rapid membrane permeabilisation without causing
overt cell lysis, as observed with the TEM and Sytox Green staining
images. TC19, TC84 and BP2 at sub-lethal concentrations initiated a
stress response distinctively diﬀerent from known antimicrobials. We
compared the response with responses observed upon treatments that
target the cell envelope by inhibiting cell wall synthesis (D-cycloserine,
oxacillin, ristocetin, bacitracin, vancomycin and amoxicillin), distorting
the cell membrane (i.e. the detergent Triton X-114), distorting the cell
membrane without causing membrane permeabilisation (the ionophore
monensin) and those that do permeabilise the membrane (gramicidin A
and polymyxin B) [23]. An independent study using a proteomic ap-
proach also found that treating Bacillus subtilis with diﬀerent membrane
active compounds does not necessarily cause a similar stress response
[97]. Our AMPs induced a stress response most similar to Triton X-114.
Triton X-114 is a non-ionic detergent that causes a phase-separation
and is often used to solubilize and separate proteins during extraction
[98].
Fig. 8. Delocalization of proteins involved in various
cellular processes after peptide treatment. B. subtilis
mutants producing proteins fused to green ﬂuor-
escent protein (GFP) were treated with lethal con-
centrations of TC19 (14 μM), TC84 (14 μM) and BP2
(3.5 μM) for 5min. The B. subtilis mutants expressed
proteins involved in cell wall synthesis (MurG-GFP,
MraY-GFP, PBP2b-GFP, PonA-GFP, MreB-GFP and
FtsW-GFP), cell membrane synthesis (PgsA-GFP and
PlsX-GFP), cell division (FtsZ-GFP, DivIVA-GFP),
ATP synthesis (AtpA-GFP), Krebs' cycle and respira-
tion (SdhA-GFP), transcription (RpoC-GFP), transla-
tion (RpsB-GFP) and DNA repair (DnaN-GFP and
RecA-GFP). The comparison of images of treated and
untreated cells showed that all proteins delocalized
except proteins involved in transcription, transla-
tion, and DNA repair. Localization of proteins in
untreated test conditions should not be over inter-
preted. Scale bar represent 2 μm.
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TC19, TC84 and BP2 induced a cell envelope stress response (CESR)
by upregulating genes regulated by Sigma factors M, V, W and X and
two component regulator systems (TCSs). B. subtilis responded to TC19
and TC84 similarly as when exposed to the natural cationic alpha-he-
lical AMP LL-37 [99], by upregulating genes controlled by the LiaRS,
YxdJK, and BceRS TCS regulators [26]. The YxdJK TCS has only been
associated with cell membrane perturbation [26], but the LiaRS TCS
have been linked with both cell wall synthesis inhibition and membrane
perturbation [24–29]. The BceRS TCS and its cognate ABC transporters,
BceAB, are upregulated in response to bacitracin and vancomycin, and
are associated with cell wall synthesis inhibition [24, 30, 31]. Ad-
ditionally, B. subtilis diﬀerentially upregulated the YtrA regulon in re-
sponse to TC19 and TC84. The YtrA regulon has been associated with
exposure to cell wall synthesis inhibiting compounds [24, 25, 32].
These ﬁndings suggest that TC19 and TC84 target the cell wall archi-
tecture and/or synthesis in addition to the cell membrane. However, LL-
37 has to our knowledge not been shown to be involved in cell wall
synthesis inhibition, and the upregulation of the BceRS TCS suggest that
LL-37 is targeting cell wall synthesis. In the case of BP2, few genes were
diﬀerentially expressed in response to the peptide. We speculate that it
is due to the very rapid activity of BP2 that prevents the initiation of a
stress response similar to what was observed for TC19 and TC84. The
few genes that were upregulated suggested that BP2 might have a si-
milar cell envelope target as TC19 and TC84. However, the physiolo-
gical analysis showed that no cell wall damage or cell lysis occurred
after 5min of treatment with lethal concentrations of TC19, TC84 and
BP2. Instead, the membrane distortion caused by these peptides did
cause delocalization of proteins essential for cell wall synthesis, MurG,
MraY, MreB, PonA, PBP2b and FtsW, within 5min of treatment. Ex-
posure to LL-37 also caused delocalization of these membrane bound
proteins involved in cell wall synthesis (Fig. S5), suggesting that this
delocalization may be a general eﬀect of exposure to cationic amphi-
pathic antimicrobial peptides acting on the membrane, since delocali-
zation of membrane bound cell wall synthesis proteins has also been
reported for non-pore-forming linear hexapeptide MP196, lipopeptide
daptomycin and non-pore-forming cyclic hexapeptide cWFW [34, 83,
84]. The changes which TC19, TC84, BP2 and LL-37 cause to the
membrane must be diﬀerent to those caused by daptomycin, since
daptomycin did not aﬀect the localization of integral membrane pro-
teins MraY and PBP2b [84]. The activity of TC19, TC84 and BP2 on the
cell membrane also caused other proteins involved in cell membrane
synthesis and metabolism to delocalize. Delocalization of such proteins
prevents their normal functioning [76, 100] and will be deleterious for
the survival of the cells. The delocalization of membrane proteins in-
volved in cell wall synthesis by TC19, TC84, BP2 and LL-37 suggests
that these amphipathic AMPs have common elements in their mode of
action, some of which might be mediated through a shared secondary
structure. LL-37 and BP2 are referred to as alpha-helical [9, 99] while
we have preliminary indications that at least TC84 acquires some alpha-
helical features upon interaction with membrane mimetics (un-
published observations).
5. Conclusion
TC19, TC84 and BP2 showed to be promising candidates as anti-
microbial agents against Gram-positive bacterial cells as their mem-
brane perturbation activity causes interference with various essential
cellular processes leading to death. We observed no adaptation or re-
sistance development against TC19, TC84 and BP2. No diﬀerence in
mode of action between TC19 and TC84 was found, but BP2 was more
rapidly active compared to TC19 and TC84 which we suspect is due to
its higher cationic charge. We employed a transcriptomic approach to
elucidate the mode of action and observed that the membrane pertur-
bation caused by the cationic amphipathic peptides induced a mem-
brane and cell wall stress response. With the aid of the green ﬂuorescent
protein fused to essential proteins bound to the membrane, we were
able to establish that proteins involved in cell wall synthesis are delo-
calized. Delocalization will have a deleterious eﬀect on the normal
functioning of the proteins. Conclusively, our ﬁndings have elucidated
crucial aspects of the mode of action of TC19, TC84 and BP2. The ob-
served lack of readily emerging resistance implies signiﬁcant potential
for further preclinical studies aimed at clinical development.
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